---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-167905"
form_type: "8-K"
ticker: "GRTX"
cik: "0001563577"
company_name: "Galera Therapeutics, Inc."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:10:16.462699+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Galera Therapeutics shareholders elect two Class I directors, ratify KPMG

## Summary
- Michael Powell, Ph.D. elected with 15,141,283 votes for (76.2% of votes cast).
- Linda West elected with 15,219,991 votes for (76.6% of votes cast); broker non-votes were 8,447,493.
- KPMG LLP ratified as independent auditor for 2023 with 28,291,469 votes for, 9,547 against.
- Turnout was 28,312,177 shares, representing 65.98% of outstanding common stock.

## SEC filing metadata
- accession: 0001193125-23-167905
- form_type: 8-K
- ticker: GRTX
- cik: 0001563577
- company_name: Galera Therapeutics, Inc.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/d503234d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-167905
- JSON: https://secwatch.observer/filing/0001193125-23-167905.json
- Plain text: https://secwatch.observer/filing/0001193125-23-167905.txt

## Key facts
- Shareholder Votes
  Galera Therapeutics, Inc. shareholders approved Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Item 1 — Election of two Class I Directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Michael Powell, Ph.D. 15,141,283 4,723,401 8,447,493 Linda West 15,219,991 4,644,693 8,447,493
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm
- Shareholder Votes
  Galera Therapeutics, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 28,291,469 9,547 11,161 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.